Detection of EBV DNA in clinically ill patients from 2013 to 2023 in Beijing, China
The positive rates of EBV DNA showed sex differences and significant fluctuations between 2013 and 2023, without displaying a consistent upward trend. Persistent surveillance and heightened clinical awareness (laboratory parameters, such as ALT, AST and CD8 + DR+/CD8+) are warranted, particularly regarding IM attributable to EBV.
Authors
- Ze Su (ORCID: https://orcid.org/0009-0000-1360-0783)
- Lingjun Kong (ORCID: https://orcid.org/0000-0002-6854-4202)
- Jie Yi
- Dong Zhang (ORCID: https://orcid.org/0000-0001-5454-1396)
- Yali Liu (ORCID: https://orcid.org/0000-0002-1249-6010)
- Han Zhang (ORCID: https://orcid.org/0000-0002-9991-9409)
- Juan Du (ORCID: https://orcid.org/0000-0002-8738-7353)
- Yu Chen (ORCID: https://orcid.org/0000-0002-6953-2115)
- Qiwen Yang (ORCID: https://orcid.org/0009-0004-3996-5448)
- Ziran Wang (ORCID: https://orcid.org/0000-0001-8163-044X)
- Rui Zhang (ORCID: https://orcid.org/0000-0003-3920-7757)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
- Central Hospital of Zibo (CN)
Publication Details
- Journal
- Frontiers in Microbiology
- Published
- 2025-11-03
- DOI
- https://doi.org/10.3389/fmicb.2025.1651320
- Citations
- 1
- Primary Topic
- Viral-associated cancers and disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- National Key Research and Development Program of China